IGM Biosciences Quote - IGMS

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

15.86

Bid

6.35

Offer

21.50

Volume

0.00 Day's Range 0.00

3.81 52 Week Range 22.50

Market Cap

940.794M

Previous Close

15.86

Open

Last Trade

16.61

Last Trade Time

19:53:16

Financial Volume

VWAP

Average Volume (3m)

324,232

Shares Outstanding

59,318,669

Dividend Yield

PE Ratio

-3.82

Earnings Per Share (EPS)

-4.15

Revenue

2.13M

Net Profit

-246.42M

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking ago... IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.igmbio.com

Headquarters

Dover, Delaware, USA

Founded

IGM Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IGMS. The last closing price for IGM Biosciences was US$15.86. Over the last year, IGM Biosciences shares have traded in a share price range of US$ 3.81 to US$ 22.50.

IGM Biosciences currently has 59,318,669 shares in issue. The market capitalisation of IGM Biosciences is US$940.79 million. IGM Biosciences has a price to earnings ratio (PE ratio) of -3.82.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.44	-8.32369942197	17.3	18.37	15.27	396818	16.27328823	CS
4	5.35	50.9039010466	10.51	22.5	9.18	378131	15.55822992	CS
12	9.43	146.6562986	6.43	22.5	6.1721	324232	12.20044488	CS
26	7.07	80.4323094425	8.79	22.5	6.1721	314129	10.51613358	CS
52	8.1	104.381443299	7.76	22.5	3.81	317729	9.53410704	CS
156	-56.09	-77.956914524	71.95	76.2	3.81	352339	18.6468136	CS
260	-2.21	-12.2302158273	18.07	127.11	3.81	275683	30.04165039	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	US$ 1.68 (57.01%)	13.68M
ONCOOnconetix Inc	US$ 4.71 (40.37%)	680.71k
RGFReal Good Food Company Inc	US$ 0.5039 (36.19%)	2.4M
CDIOCardio Diagnostics Holdings Inc	US$ 0.3179 (27.16%)	8.55M
ESTAEstablishment Labs Holdings Inc	US$ 52.01 (26.25%)	20.45k
HLPHongil Group Inc	US$ 0.905 (-49.86%)	9
AYTUAYTU BioPharma Inc	US$ 2.30 (-19.27%)	2.18k
NVNOenVVeno Medical Corporation	US$ 3.71 (-17.56%)	13.29k
AIFFFirefly Neuroscience Inc	US$ 2.52 (-16.00%)	1.49k
MNTSMomentus Inc	US$ 0.4504 (-15.97%)	144.98k
XPONExpion360 Inc	US$ 0.0781 (21.27%)	26.26M
DUOFangDD Network Group Ltd	US$ 1.68 (57.01%)	13.68M
CDIOCardio Diagnostics Holdings Inc	US$ 0.3179 (27.16%)	8.55M
MTCMMTec Inc	US$ 0.3655 (9.60%)	2.44M
RGFReal Good Food Company Inc	US$ 0.5039 (36.19%)	2.4M